Breast cancer cells response to the antineoplastic agents cisplatin, carboplatin, and doxorubicin at the mRNA expression levels of distinct apoptosis-related genes, including the new member, BCL2L12. (Q40150747)
Jump to navigation
Jump to search
scientific article published on January 2007
Language | Label | Description | Also known as |
---|---|---|---|
English | Breast cancer cells response to the antineoplastic agents cisplatin, carboplatin, and doxorubicin at the mRNA expression levels of distinct apoptosis-related genes, including the new member, BCL2L12. |
scientific article published on January 2007 |
Statements
1 reference
Breast cancer cells response to the antineoplastic agents cisplatin, carboplatin, and doxorubicin at the mRNA expression levels of distinct apoptosis-related genes, including the new member, BCL2L12. (English)
1 reference
1 reference
Hellinida Thomadaki
1 reference
1 January 2007
1 reference
1 reference
1095
1 reference
35-44
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference